EdgarLookup

TARGET CORP — Financial Data

Annual figures from SEC EDGAR XBRL filings (10-K)

These figures are extracted directly from XBRL-tagged financial statements that TARGET CORP filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.

Overview All Filings Annual Quarterly Insiders
5.1%
Profit Margin
Net income ÷ revenue
6.2%
Return on Assets
Net income ÷ assets
+237.5%
Revenue Growth
Year over year

Revenue

Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.

Fiscal Year Period End Value Filed
FY2014 Jan 31, 2015 $72.62B Mar 13, 2015
FY2013 Feb 1, 2014 $21.52B Mar 14, 2014
FY2013 Nov 2, 2013 $17.26B Mar 14, 2014
FY2013 Aug 3, 2013 $17.12B Mar 14, 2014
FY2013 May 4, 2013 $16.71B Mar 14, 2014
FY2013 Feb 2, 2013 $22.73B Mar 14, 2014
FY2013 Oct 27, 2012 $16.93B Mar 14, 2014
FY2013 Jul 28, 2012 $16.78B Mar 14, 2014
FY2013 Apr 28, 2012 $16.87B Mar 14, 2014
FY2011 Jan 28, 2012 $21.29B Mar 15, 2012

Revenue

Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.

Fiscal Year Period End Value Filed
FY2025 Jan 31, 2026 $104.78B Mar 11, 2026
FY2025 Feb 1, 2025 $106.57B Mar 11, 2026
FY2025 Feb 3, 2024 $107.41B Mar 11, 2026
FY2024 Jan 28, 2023 $109.12B Mar 12, 2025
FY2023 Jan 29, 2022 $106.01B Mar 13, 2024
FY2022 Jan 30, 2021 $93.56B Mar 8, 2023
FY2019 Feb 1, 2020 $23.40B Mar 11, 2020
FY2019 Nov 2, 2019 $18.67B Mar 11, 2020
FY2019 Aug 3, 2019 $18.42B Mar 11, 2020
FY2019 May 4, 2019 $17.63B Mar 11, 2020

Revenue (Net Sales)

Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.

Fiscal Year Period End Value Filed
FY2017 Feb 3, 2018 $22.77B Mar 14, 2018
FY2017 Oct 28, 2017 $16.67B Mar 14, 2018
FY2017 Jul 29, 2017 $16.43B Mar 14, 2018
FY2017 Apr 29, 2017 $16.02B Mar 14, 2018
FY2016 Jan 28, 2017 $20.69B Mar 8, 2017
FY2016 Oct 29, 2016 $16.44B Mar 8, 2017
FY2016 Jul 30, 2016 $16.17B Mar 8, 2017
FY2016 Apr 30, 2016 $16.20B Mar 8, 2017
FY2015 Jan 30, 2016 $21.63B Mar 11, 2016
FY2015 Oct 31, 2015 $17.61B Mar 11, 2016

Gross Profit

Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.

Fiscal Year Period End Value Filed
FY2017 Feb 3, 2018 $5.97B Mar 14, 2018
FY2017 Oct 28, 2017 $4.96B Mar 14, 2018
FY2017 Jul 29, 2017 $5.01B Mar 14, 2018
FY2017 Apr 29, 2017 $4.82B Mar 14, 2018
FY2016 Jan 28, 2017 $5.57B Mar 8, 2017
FY2016 Oct 29, 2016 $4.97B Mar 8, 2017
FY2016 Jul 30, 2016 $5.07B Mar 8, 2017
FY2016 Apr 30, 2016 $5.01B Mar 8, 2017
FY2015 Jan 30, 2016 $6.03B Mar 11, 2016
FY2015 Oct 31, 2015 $5.17B Mar 11, 2016

Net Income

The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.

Fiscal Year Period End Value Filed
FY2025 Jan 31, 2026 $3.71B Mar 11, 2026
FY2025 Feb 1, 2025 $4.09B Mar 11, 2026
FY2025 Feb 3, 2024 $4.14B Mar 11, 2026
FY2024 Jan 28, 2023 $2.78B Mar 12, 2025
FY2023 Jan 29, 2022 $6.95B Mar 13, 2024
FY2022 Jan 30, 2021 $4.37B Mar 8, 2023

Operating Income

Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.

Fiscal Year Period End Value Filed
FY2025 Jan 31, 2026 $5.12B Mar 11, 2026
FY2025 Feb 1, 2025 $5.57B Mar 11, 2026
FY2025 Feb 3, 2024 $5.71B Mar 11, 2026
FY2024 Jan 28, 2023 $3.85B Mar 12, 2025
FY2023 Jan 29, 2022 $8.95B Mar 13, 2024
FY2022 Jan 30, 2021 $6.54B Mar 8, 2023
FY2019 Feb 1, 2020 $1.20B Mar 11, 2020
FY2019 Nov 2, 2019 $1.00B Mar 11, 2020
FY2019 Aug 3, 2019 $1.32B Mar 11, 2020
FY2019 May 4, 2019 $1.14B Mar 11, 2020

SG&A Expense

Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.

Fiscal Year Period End Value Filed
FY2025 Jan 31, 2026 $21.54B Mar 11, 2026
FY2025 Feb 1, 2025 $21.97B Mar 11, 2026
FY2025 Feb 3, 2024 $21.46B Mar 11, 2026
FY2024 Jan 28, 2023 $20.58B Mar 12, 2025
FY2023 Jan 29, 2022 $19.75B Mar 13, 2024
FY2022 Jan 30, 2021 $18.62B Mar 8, 2023
FY2019 Feb 1, 2020 $4.50B Mar 11, 2020
FY2019 Nov 2, 2019 $4.15B Mar 11, 2020
FY2019 Aug 3, 2019 $3.91B Mar 11, 2020
FY2019 May 4, 2019 $3.66B Mar 11, 2020

Operating Cash Flow

Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.

Fiscal Year Period End Value Filed
FY2025 Jan 31, 2026 $6.56B Mar 11, 2026
FY2025 Feb 1, 2025 $7.37B Mar 11, 2026
FY2025 Feb 3, 2024 $8.62B Mar 11, 2026
FY2024 Jan 28, 2023 $4.02B Mar 12, 2025
FY2023 Jan 29, 2022 $8.63B Mar 13, 2024
FY2022 Jan 30, 2021 $10.53B Mar 8, 2023
FY2021 Feb 1, 2020 $7.12B Mar 9, 2022
FY2020 Feb 2, 2019 $5.97B Mar 10, 2021
FY2019 Feb 3, 2018 $6.94B Mar 11, 2020
FY2018 Jan 28, 2017 $5.44B Mar 13, 2019

Capital Expenditures (Capex)

Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.

Fiscal Year Period End Value Filed
FY2025 Jan 31, 2026 $3.73B Mar 11, 2026
FY2025 Feb 1, 2025 $2.89B Mar 11, 2026
FY2025 Feb 3, 2024 $4.81B Mar 11, 2026
FY2024 Jan 28, 2023 $5.53B Mar 12, 2025
FY2023 Jan 29, 2022 $3.54B Mar 13, 2024
FY2022 Jan 30, 2021 $2.65B Mar 8, 2023
FY2021 Feb 1, 2020 $3.03B Mar 9, 2022
FY2020 Feb 2, 2019 $3.52B Mar 10, 2021
FY2019 Feb 3, 2018 $2.53B Mar 11, 2020
FY2018 Jan 28, 2017 $1.55B Mar 13, 2019

Total Assets

The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.

Fiscal Year Period End Value Filed
FY2025 Jan 31, 2026 $59.49B Mar 11, 2026
FY2025 Feb 1, 2025 $57.77B Mar 11, 2026
FY2024 Feb 3, 2024 $55.36B Mar 12, 2025
FY2023 Jan 28, 2023 $53.34B Mar 13, 2024
FY2022 Jan 29, 2022 $53.81B Mar 8, 2023
FY2021 Jan 30, 2021 $51.25B Mar 9, 2022
FY2020 Feb 1, 2020 $42.78B Mar 10, 2021
FY2019 Feb 2, 2019 $41.29B Mar 11, 2020
FY2018 Feb 3, 2018 $40.30B Mar 13, 2019
FY2017 Jan 28, 2017 $37.43B Mar 14, 2018

Stockholders Equity

The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.

Fiscal Year Period End Value Filed
FY2025 Jan 31, 2026 $16.17B Mar 11, 2026
FY2025 Feb 1, 2025 $14.67B Mar 11, 2026
FY2025 Feb 3, 2024 $13.43B Mar 11, 2026
FY2025 Jan 28, 2023 $11.23B Mar 11, 2026
FY2024 Jan 29, 2022 $12.83B Mar 12, 2025
FY2023 Jan 30, 2021 $14.44B Mar 13, 2024
FY2022 Feb 1, 2020 $11.83B Mar 8, 2023
FY2021 Feb 2, 2019 $11.30B Mar 9, 2022
FY2020 Feb 3, 2018 $11.65B Mar 10, 2021
FY2019 Jan 28, 2017 $10.92B Mar 11, 2020

Goodwill

An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.

Fiscal Year Period End Value Filed
FY2025 Jan 31, 2026 $631.00M Mar 11, 2026
FY2025 Feb 1, 2025 $631.00M Mar 11, 2026
FY2024 Feb 3, 2024 $631.00M Mar 12, 2025
FY2023 Jan 28, 2023 $631.00M Mar 13, 2024
FY2022 Jan 29, 2022 $631.00M Mar 8, 2023
FY2021 Jan 30, 2021 $631.00M Mar 9, 2022
FY2020 Feb 1, 2020 $633.00M Mar 10, 2021
FY2019 Feb 2, 2019 $633.00M Mar 11, 2020
FY2018 Feb 3, 2018 $630.00M Mar 13, 2019
FY2017 Jan 28, 2017 $133.00M Mar 14, 2018

Retained Earnings

Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.

Fiscal Year Period End Value Filed
FY2025 Jan 31, 2026 $9.30B Mar 11, 2026
FY2025 Feb 1, 2025 $8.09B Mar 11, 2026
FY2024 Feb 3, 2024 $7.09B Mar 12, 2025
FY2023 Jan 28, 2023 $5.01B Mar 13, 2024
FY2022 Jan 29, 2022 $6.92B Mar 8, 2023
FY2021 Jan 30, 2021 $8.83B Mar 9, 2022
FY2020 Feb 1, 2020 $6.43B Mar 10, 2021
FY2019 Feb 2, 2019 $6.02B Mar 11, 2020
FY2018 Feb 3, 2018 $6.50B Mar 13, 2019
FY2017 Jan 28, 2017 $5.88B Mar 14, 2018

Long-Term Debt

Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.

Fiscal Year Period End Value Filed
FY2025 Jan 31, 2026 $14.40B Mar 11, 2026
FY2025 Feb 1, 2025 $13.90B Mar 11, 2026
FY2024 Feb 3, 2024 $14.15B Mar 12, 2025
FY2023 Jan 28, 2023 $14.14B Mar 13, 2024
FY2022 Jan 29, 2022 $11.57B Mar 8, 2023
FY2020 Jan 30, 2021 $10.64B Mar 10, 2021
FY2019 Feb 1, 2020 $9.99B Mar 11, 2020
FY2018 Feb 2, 2019 $10.25B Mar 13, 2019
FY2017 Feb 3, 2018 $10.44B Mar 14, 2018
FY2016 Jan 28, 2017 $11.72B Mar 8, 2017

EPS (Basic)

Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.

Fiscal Year Period End Value Filed
FY2025 Jan 31, 2026 8 Mar 11, 2026
FY2025 Feb 1, 2025 8 Mar 11, 2026
FY2025 Feb 3, 2024 8 Mar 11, 2026
FY2024 Jan 28, 2023 6 Mar 12, 2025
FY2023 Jan 29, 2022 14 Mar 13, 2024
FY2022 Jan 30, 2021 8 Mar 8, 2023
FY2019 Feb 1, 2020 1 Mar 11, 2020
FY2019 Nov 2, 2019 1 Mar 11, 2020
FY2019 Aug 3, 2019 1 Mar 11, 2020
FY2019 May 4, 2019 1 Mar 11, 2020

EPS (Diluted)

Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.

Fiscal Year Period End Value Filed
FY2025 Jan 31, 2026 8 Mar 11, 2026
FY2025 Feb 1, 2025 8 Mar 11, 2026
FY2025 Feb 3, 2024 8 Mar 11, 2026
FY2024 Jan 28, 2023 5 Mar 12, 2025
FY2023 Jan 29, 2022 14 Mar 13, 2024
FY2022 Jan 30, 2021 8 Mar 8, 2023
FY2019 Feb 1, 2020 1 Mar 11, 2020
FY2019 Nov 2, 2019 1 Mar 11, 2020
FY2019 Aug 3, 2019 1 Mar 11, 2020
FY2019 May 4, 2019 1 Mar 11, 2020

Shares Outstanding

Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.

Fiscal Year Period End Value Filed
FY2025 Jan 31, 2026 452.84M Mar 11, 2026
FY2025 Feb 1, 2025 455.57M Mar 11, 2026
FY2024 Feb 3, 2024 461.68M Mar 12, 2025
FY2023 Jan 28, 2023 460.35M Mar 13, 2024
FY2022 Jan 29, 2022 471.27M Mar 8, 2023
FY2021 Jan 30, 2021 500.88M Mar 9, 2022
FY2020 Feb 1, 2020 504.20M Mar 10, 2021
FY2019 Feb 2, 2019 517.76M Mar 11, 2020
FY2018 Feb 3, 2018 541.68M Mar 13, 2019
FY2017 Jan 28, 2017 556.16M Mar 14, 2018

Dividends Paid

Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.

Fiscal Year Period End Value Filed
FY2025 Jan 31, 2026 $2.05B Mar 11, 2026
FY2025 Feb 1, 2025 $2.05B Mar 11, 2026
FY2025 Feb 3, 2024 $2.01B Mar 11, 2026
FY2024 Jan 28, 2023 $1.84B Mar 12, 2025
FY2023 Jan 29, 2022 $1.55B Mar 13, 2024
FY2022 Jan 30, 2021 $1.34B Mar 8, 2023
FY2021 Feb 1, 2020 $1.33B Mar 9, 2022
FY2020 Feb 2, 2019 $1.34B Mar 10, 2021
FY2019 Feb 3, 2018 $1.34B Mar 11, 2020
FY2018 Jan 28, 2017 $1.35B Mar 13, 2019